Rubius Therapeutics, Inc.

Ownership Transactions Reported by 14 Insiders

Industry: Biological Products, (No Diagnostic Substances)
Location: C/O Verdolino & Lowey, P.C., 124 Washington Street, Suite 101, Foxboro, MA

There are no Buy or Sell transactions made by insiders since 11/21/2023

Rubius Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Noubar Afeyan	Director, 10%+ Owner				May 12, 2022
Francis M. Cuss	Director				May 12, 2022
Natalie C. Holles	Director				May 12, 2022
Jonathan Symonds	Director				May 12, 2022
Maiken Keson-Brookes	CLO & Corp. Secretary				Jan 29, 2022
Anne Prener	Director				May 12, 2022
Dannielle Appelhans	CEO and President				Feb 24, 2023
Laurence A. Turka	Chief Scientific Officer				Jan 29, 2023
Pablo J. Cagnoni	Director				Feb 1, 2023
Catherine A. Sohn	Director				May 12, 2022
David R. Epstein	Director				May 12, 2022
Jose Carmona	Chief Financial Officer				Jan 31, 2022
Michael Rosenblatt	Director				May 12, 2022
Susanne Schaffert	Director				Jul 29, 2022

Recent Insider Transactions by Companies or Individuals for Rubius Therapeutics, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.